As GLP-1s quiet the constant hum of hunger, are they a permanent pharmaceutical crutch, or can they create space to let us ...

A Monell Chemical Senses Center study published this week in the Journal of Clinical Investigation offers renewed hope for ...

Both GLP-1 receptor agonists and SGLT2 inhibitors linked to reduced risk for ADRD, with no significant difference between them.

A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between ...

“There is some evidence that there is altered brain activity related to reward-related behaviors, including appetite and ...

Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

Diabetic kidney disease is chronic kidney disease that occurs as a complication of diabetes. Learn about its signs and ...

When I started taking a GLP-1 medication in October, I knew it would probably change a few things—our weekly dinner plan, how ...

But these drugs do expire after a few weeks, and microdosing could increase the risk of inadvertently using them after their ...

As a large proportion of people taking medications like Mounjaro, Ozempic and Wegovy for weight loss report consuming less processed foods and soda, researchers say food and beverage companies are ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...